Ignite Creation Date:
2024-05-06 @ 10:05 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03157128
Status:
RECRUITING
Last Update Posted:
2024-03-04
First Post:
2017-05-09
Brief Title:
A Study of Selpercatinib LOXO-292 in Participants With Advanced Solid Tumors RET Fusion-Positive Solid Tumors and Medullary Thyroid Cancer LIBRETTO-001
Sponsor:
Loxo Oncology Inc
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-09
First Submit QC Date:
May 15 2017
Study First Post Date:
2017-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-01
Last Update Post Date:
2024-03-04
Last Update Post Date Type:
ACTUAL